Henan Lingrui Pharmaceutical Co (SHSE:600285) EBIT per Share : ¥1.24 (TTM As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Henan Lingrui Pharmaceutical Co EBIT per Share?

Henan Lingrui Pharmaceutical Co's EBIT per Share for the three months ended in Mar. 2024 was ¥0.39. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.24.

During the past 12 months, the average EBIT per Share Growth Rate of Henan Lingrui Pharmaceutical Co was 45.00% per year. During the past 3 years, the average EBIT per Share Growth Rate was 22.20% per year. During the past 5 years, the average EBIT per Share Growth Rate was 13.30% per year. During the past 10 years, the average EBIT per Share Growth Rate was 22.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Henan Lingrui Pharmaceutical Co's EBIT per Share or its related term are showing as below:

SHSE:600285' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -21 Med: 17.85 Max: 55.1
Current: 22.2

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Henan Lingrui Pharmaceutical Co was 55.10% per year. The lowest was -21.00% per year. And the median was 17.85% per year.

SHSE:600285's 3-Year EBIT Growth Rate is ranked better than
70.22% of 863 companies
in the Drug Manufacturers industry
Industry Median: 7.3 vs SHSE:600285: 22.20

Henan Lingrui Pharmaceutical Co's EBIT for the three months ended in Mar. 2024 was ¥221 Mil.

Henan Lingrui Pharmaceutical Co EBIT per Share Historical Data

The historical data trend for Henan Lingrui Pharmaceutical Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Henan Lingrui Pharmaceutical Co EBIT per Share Chart

Henan Lingrui Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

0.61

0.64

0.73

0.91

1.15

Henan Lingrui Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial															0.30	0.34	0.31	0.20	0.39

Henan Lingrui Pharmaceutical Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Henan Lingrui Pharmaceutical Co's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	652.864	/	566.410
=	1.15

Henan Lingrui Pharmaceutical Co's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	220.965	/	566.603
=	0.39

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.24

Henan Lingrui Pharmaceutical Co (SHSE:600285) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Henan Lingrui Pharmaceutical Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of Henan Lingrui Pharmaceutical Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Henan Lingrui Pharmaceutical Co (SHSE:600285) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) » Definitions » EBIT per Share

Traded in Other Exchanges

N/A

Address

No. 59 Jiefang Chengguan Road, Xinxian, Xinyang, Henan, CHN, 465550

Website

http://www.lingrui.com

Henan Lingrui Pharmaceutical Co Ltd is a Chinese company engaged in the development, production, and distribution of pharmaceuticals. The Company's products include tablets, capsules, injections and other medicines.

Executives

Wu Xi Zhen	Director
Li Jin	Supervisors
Ye Qiang	senior management
Chen Yan	Directors, senior managers
Wu Hui Bin	senior management
Yu Peng	Director
Zhao Zhi Jun	Director
Li Lei	senior management
Feng Guo Xin	Directors, senior managers
Pan Zi Run	Director
Xiong Wei Zheng	Director
Tang Wei	Supervisors
Cheng Jian Jun	Director
Zhang Jun Bing	Director
Xia Hui	senior management

Henan Lingrui Pharmaceutical Co (SHSE:600285) Headlines

No Headlines